Molecular Insight Balance Sheet
View: Annual
| Assets | Dec 07 | Dec 06 | Dec 05 |
|---|---|---|---|
| Current Assets | |||
| Cash | 119.2 | 8.9 | 18.4 |
| Net Receivables | 0.3 | 0.1 | 0.3 |
| Inventories | -- | -- | -- |
| Other Current Assets | 1.5 | 1.6 | 0.4 |
| Total Current Assets | 121.0 | 10.6 | 19.1 |
| Net Fixed Assets | 4.7 | 0.9 | 0.5 |
| Other Noncurrent Assets | 51.0 | 1.4 | 0.1 |
| Total Assets | 176.7 | 12.9 | 19.6 |
| Liabilities and Shareholder's Equity | Dec 07 | Dec 06 | Dec 05 |
| Current Liabilities | |||
| Accounts Payable | 15.0 | 7.9 | 4.4 |
| Short-Term Debt | -- | 1.7 | 1.7 |
| Other Current Liabilities | -- | 0.3 | -- |
| Total Current Liabilities | 15.0 | 10.0 | 6.1 |
| Long-Term Debt | 133.1 | 16.7 | 3.4 |
| Other Noncurrent Liabilities | -- | 0.0 | 0.1 |
| Total Liabilities | 148.1 | 26.7 | 9.6 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | -- | 48.1 | 45.2 |
| Common Stock Equity | 28.6 | (61.9) | (35.1) |
| Total Equity | 28.6 | (61.9) | (35.1) |
| Shares Outstanding (mil.) | 25.0 | 4.6 | 4.5 |






